Inventor
MANDAL DEBASHIS
US14 patents
⚠️ This page may combine multiple inventors who share the name “MANDAL DEBASHIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARCUS BIOSCIENCES INC
9 patentsUS10399962B2Sep 3, 2019
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC13 citations80
US11787762B2Oct 17, 2023
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
ARCUS BIOSCIENCES INC2 citations69
US11407712B2Aug 9, 2022
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
ARCUS BIOSCIENCES INC3 citations69
US11072597B2Jul 27, 2021
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC3 citations69
US12195447B2Jan 14, 2025
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC1 citations60
US12103907B2Oct 1, 2024
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
ARCUS BIOSCIENCES INC0 citations59
US11931343B2Mar 19, 2024
CD73 inhibitors
ARCUS BIOSCIENCES INC0 citations48
US12226425B2Feb 18, 2025
Inhibitors of ARG1 and/or ARG2
ARCUS BIOSCIENCES INC0 citations47
US12064433B2Aug 20, 2024
Pyridone A2R antagonists
ARCUS BIOSCIENCES INC0 citations47
UNIV RICE WILLIAM M
4 patentsUS9777013B2Oct 3, 2017
Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents
UNIV RICE WILLIAM M4 citations73
US10889590B2Jan 12, 2021
Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents
UNIV RICE WILLIAM M0 citations62
US10808007B2Oct 20, 2020
Desacetoxytubulysin H and analogs thereof
UNIV RICE WILLIAM M1 citations56
US10233192B2Mar 19, 2019
Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents
UNIV RICE WILLIAM M0 citations52